Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

Defective angiogenesis underlies over 50 malignant, ischemic and inflammatory disorders yet long-term therapeutic applications inevitably fail, thus highlighting the need for greater understanding of the vast crosstalk and compensatory mechanisms. Based on proteomic profiling of angiogenic endothelial components, here we report βIV-spectrin, a non-erythrocytic cytoskeletal protein, as a critical regulator of sprouting angiogenesis. Early loss of endothelial-specific βIV-spectrin promotes embryonic lethality in mice due to hypervascularization and hemorrhagic defects whereas neonatal depletion yields higher vascular density and tip cell populations in developing retina. During sprouting, βIV-spectrin expresses in stalk cells to inhibit their tip cell potential by enhancing VEGFR2 turnover in a manner independent of most cell-fate determining mechanisms. Rather, βIV-spectrin recruits CaMKII to the plasma membrane to directly phosphorylate VEGFR2 at Ser984, a previously undefined phosphoregulatory site that strongly induces VEGFR2 internalization and degradation. These findings support a distinct spectrin-based mechanism of tip-stalk cell specification during vascular development. © 2022. The Author(s).

Citation

Eun-A Kwak, Christopher C Pan, Aaron Ramonett, Sanjay Kumar, Paola Cruz-Flores, Tasmia Ahmed, Hannah R Ortiz, Jeffrey J Lochhead, Nathan A Ellis, Ghassan Mouneimne, Teodora G Georgieva, Yeon Sun Lee, Todd W Vanderah, Tally Largent-Milnes, Peter J Mohler, Thomas J Hund, Paul R Langlais, Karthikeyan Mythreye, Nam Y Lee. βIV-spectrin as a stalk cell-intrinsic regulator of VEGF signaling. Nature communications. 2022 Mar 14;13(1):1326

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 35288568

View Full Text